Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2007
11/08/2007WO2007126117A1 Phenyl 5-thioglucoside compound
11/08/2007WO2007126083A1 Method for stabilization of reduced coenzyme q10
11/08/2007WO2007126043A1 Use as drugs of carboxylic acid derivatives having thiazole rings
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125915A1 Solid matter containing coenzyme q
11/08/2007WO2007125720A1 Molecular chaperone expression inducer
11/08/2007WO2007125644A1 Fat absorption inhibitor
11/08/2007WO2007125621A1 Novel use of gene whose expression is increased in hyperplastic pancreatic islet
11/08/2007WO2007125405A2 Substituted 2-amino-fused heterocyclic compounds
11/08/2007WO2007125351A1 Pyrimidine derivatives for the treatment of amyloid-related diseases
11/08/2007WO2007125243A1 Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity
11/08/2007WO2007125103A2 Benzamide glucokinase activators
11/08/2007WO2007125049A1 Use of cbx cannabinoid receptor modulators as potassium channel modulators
11/08/2007WO2007125048A1 Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators
11/08/2007WO2007124734A2 Compounds a-r-x for the manufacture of pharmaceutical preparations
11/08/2007WO2007124668A1 Pharmaceutical composition comprising high concentrate of polydatin
11/08/2007WO2007124618A1 Insulin-like growth factor-enriched nano-products of hairy antler and process for preparation thereof
11/08/2007WO2007124617A1 Coumarin derivatives, their preparation methods and their pharmaceutic compositions and uses
11/08/2007WO2007109884A8 Fat-trapping composition comprising an indigestible cationic polysaccharide and an emulsifying agent
11/08/2007WO2007109037A3 Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
11/08/2007WO2007089557A3 Polycyclic 1, 2, 3, 4 -tetrahydro- isoquinoline derivatives and compositions comprising them as ppar modulators
11/08/2007WO2007075534A3 Polymer conjugates of glp-1
11/08/2007WO2007074406A3 Formulations for treatment of lipoprotein abnormalities comprising a statin a statin and a methylnicotinamide derivative
11/08/2007WO2007071357A3 Pharmaceutical composition comprising (e) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5 -yl- (3r, 5s) -3, 5-dihydr0xyhept-6-en0ic acid
11/08/2007WO2007038801A3 Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
11/08/2007WO2006106423A8 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
11/08/2007WO2002046458A9 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
11/08/2007WO2002022146A3 Components of canola for treating hyperlipidemia
11/08/2007US20070259961 Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal or cancer
11/08/2007US20070259927 Remedy for Diabetes
11/08/2007US20070259925 Dpp iv inhibitors
11/08/2007US20070259918 2-Hydroxymethyl-3,4,5-Trihydroxy-1-(4-Pentyloxybenzyl) Piperidine as Glucosylceramide Synthase (Gcs) Inhibitor
11/08/2007US20070259908 Mitochondria Activators
11/08/2007US20070259904 Bi-aryl meta-pyrimidine inhibitors of kinases
11/08/2007US20070259902 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
11/08/2007US20070259896 N-[3-(3-{[5-(4-Fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy}propoxy)phenyl]cyclopropanecarboxamide; PDE10 inhibitor; psychological, nervous system disorders; schizophrenia; cognition activators; drug abuse; antiepileptic agents; lupus; antitumor, -carcinogenic agents; hyperglycemica agents; sarcoidosis
11/08/2007US20070259891 Heterocycle-Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors
11/08/2007US20070259887 Inhibitors of polyq-aggregation
11/08/2007US20070259884 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
11/08/2007US20070259883 Substitued A-Piperazingly Phenylpropionic Acid Derivatives As Hppar Alpha And/Or Hppar Gamma Agonists
11/08/2007US20070259880 dipeptidyl peptidase IV (DPP-IV) inhibitors, useful for the prophylaxis or treatment of non-insulin dependent diabetes and obesity
11/08/2007US20070259872 Inhibitors of soluble adenylate cyclase
11/08/2007US20070259815 Albumin fusion proteins
11/08/2007US20070259061 Extract oily phase by cold press and solvent; use as nutritional supplements, in cosmetics
11/08/2007US20070259057 Wrinkle Reduction Agent, Lipolysis Accelerator, Composition for External Use on Skin, and Food or Beverage Composition
11/08/2007US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof
11/08/2007US20070258974 Diagnostics and Therapeutics for Diseases Associated with Puromycin Sensitive Aminopeptidase Npepps (Npepps)
11/08/2007US20070258961 Cholesterol efflux and uses thereof
11/08/2007US20070258920 Process for obtaining polyphenol extracts from cocoa beans, the resulting extracts and uses thereof
11/08/2007CA2684999A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
11/08/2007CA2669708A1 Benzamide glucokinase activators
11/08/2007CA2651072A1 Substituted 2-amino-fused heterocyclic compounds
11/08/2007CA2650686A1 Method for stabilization of reduced coenzyme q10
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007CA2650638A1 Methods for treating diabetes
11/08/2007CA2650627A1 Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2650577A1 Use of 12-imidazolyl-1-dodecanol or its pharmaceutically acceptable salts for producing a pharmaceutical preparation
11/08/2007CA2650567A1 Use of cbx cannabinoid receptor modulators as potassium channel modulators
11/08/2007CA2650566A1 Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators
11/08/2007CA2650403A1 Compositions comprising theaflavins and gallates thereof useful as fat absorption inhibitors
11/08/2007CA2650389A1 Pyrimidine derivatives for the treatment of amyloid-related diseases
11/08/2007CA2650132A1 Further medical uses of antisecretory protein
11/08/2007CA2649822A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2649650A1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2649577A1 Benzamide glucokinase activators
11/08/2007CA2649363A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitor activity
11/08/2007CA2649111A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2648773A1 Multi-membrane immunoisolation system for cellular transplant
11/08/2007CA2648236A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2648019A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2647815A1 Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia
11/08/2007CA2647678A1 Diazepan orexin receptor antagonists
11/08/2007CA2646624A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2634871A1 Treatment of renal disorders, diabetic nephopathy and dyslipidemias
11/07/2007EP1852505A1 Mutations in ion channels
11/07/2007EP1852503A1 Il-13 production inhibitor
11/07/2007EP1852439A1 Spiroketal derivative and use thereof as diabetic medicine
11/07/2007EP1852433A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
11/07/2007EP1852427A1 Biologically active 4H-Benzo [1,4] oxazin-3-ones
11/07/2007EP1852426A1 Process for production of optically active ppar-activating compound and intermediate of the same
11/07/2007EP1852423A1 Crystal of 4(3h)-quinazolinone derivative
11/07/2007EP1852116A1 Pharmaceutical compositions of amlodipine and atorvastatin
11/07/2007EP1852108A1 DPP IV inhibitor formulations
11/07/2007EP1851216A2 Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes
11/07/2007EP1851205A2 Pyridazine derivatives and their use as therapeutic agents
11/07/2007EP1851204A1 Naphthalene derivatives as modulators of the glucocorticoid receptor
11/07/2007EP1851202A1 Pyridyl acetic acid compounds
11/07/2007EP1851197A2 Phenylazetidinone derivatives
11/07/2007EP1850848A1 Tetracyclic sulfonamide compounds and methods of use thereof
11/07/2007EP1850845A2 Formulations and dosing regimen for ppar-alpha modulators
11/07/2007EP1850844A2 Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors
11/07/2007EP1804795A4 Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
11/07/2007EP1623977B1 Intermediate compound which is used for the preparation of pioglitazone
11/07/2007EP1613597B1 6-substituted nicotinamide derivatives as opioid receptor antagonists
11/07/2007EP1572203B1 Substituted 4-alkoxyoxazol derivatives as ppar agonists
11/07/2007EP1523486B1 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
11/07/2007EP1513526B1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
11/07/2007EP1423707B1 Methods of screening molecules that are used to prevent cardiovascular diseases
11/07/2007EP1361225B1 Compounds substituted with bicyclic amino groups
11/07/2007EP1257281B1 Nucleoside analogs with carboxamidine modified monocyclic base